Anti-EGFR Skincare

Healthcare
Professional Site

Welcome ...
to anti-egfr-skincare.com™. This website contains information, treatment algorithms and educational materials for healthcare professionals (HCPs) relating to the management of dermatological toxicities in patients treated with antibodies and small-molecule inhibitors directed towards the epidermal growth factor receptor (EGFR).

Username Password

Patient and
Caregiver Site

Welcome …
to anti-egfr-skincare.com™. This website provides you with information about skin problems that may occur when being treated against cancer with anti-EGFR drugs, such as Erbitux™ (Cetuximab), Iressa™ (Gefitinib), Tarceva™ (Erlotinib), Vectibix™ (Panitumumab). When being treated, you are likely to have some skin problems. Usually these are mild but sometimes they can be more severe, especially if not treated quickly and correctly.

The information provided on this website will help you to minimise the impact of these skin reactions on your daily life. You will find guidance on what you can do, what you should avoid doing, when you should contact your doctor or nurse, and other practical tips.

I hereby confirm that I have read and understood the disclaimer

Patient and Caregiver Access

This site contains information and education for healthcare professionals. Information presented in the native language within each country's website is governed by laws and regulations of that particular country, and therefore is intended for healthcare professionals in that country only.

I am
U.S. resident

I am a patient
outside the U.S.

I am an HCP
outside the U.S.

Healthcare
Professional Site

Patient and
Caregiver Site

Patient and Caregiver Access

I am U.S. resident

I am a patient outside the U.S.

I am an HCP outside the U.S.

Healthcare Professional Site

Login

Patient and Caregiver Site

Patient and Caregiver Access

I am
U.S. resident

I am a patient
outside the U.S.

I am an HCP
outside the U.S.

Healthcare
Professional Site

Patient and
Caregiver Site